Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Sentynl and Fortress 'COMEBACK' with its Menkes disease therapy
Date 16 January 2026

Sentynl and Fortress 'COMEBACK' with its Menkes disease therapy

Introduction Sentynl Therapeutics, a U.S. biopharmaceutical company with its exclusive Zydus Lifesciences, centralising its aim at first place for establishing and introducing specialised, effective ...

SGT-212 received Orphan Drug Designation to treat Friedreich's Ataxia
Date 15 January 2026

SGT-212 received Orphan Drug Designation to treat Friedreich's Ataxia

Introduction Solid Biosciences Inc. is a leading precision genetic medicine company concentrating on gene therapies for cardiac disease, rare neuromuscular diseases, and mainly for Friedreich’s...

EMD Serono received FDA approval for its NDA, curing Tenosynovial Giant Cell Tumor
Date 15 January 2026

EMD Serono received FDA approval for its NDA, curing Tenosynovial Giant Cell Tumor

Introduction EMD Serono, a strong business of Merck KGaA, is a polished tech and global science company known for the creative and unique treatment for complicated diseases such as cancer, infertilit...

BioVaxys's study results are out, featuring improvement of DPXâ„¢
Date 13 January 2026

BioVaxys's study results are out, featuring improvement of DPXâ„¢

Introduction BioVaxys Technology Corp. is a clinically devoted biotechnology company that promises to introduce novel immunotherapies involving antiviral vaccines and cancer. The company’s excl...

Protara completes first patient dosing, taking one step ahead in its THRIVE-3 Trial
Date 12 January 2026

Protara completes first patient dosing, taking one step ahead in its THRIVE-3 Trial

Introduction Protara Therapeutics, Inc. is a leading clinical-level biopharmaceutical company that has worked wonders in establishing life-changing, effective therapies for rare diseases and cancer. ...

Jazz shows progress in stomach cancer with its promising findings
Date 12 January 2026

Jazz shows progress in stomach cancer with its promising findings

Introduction Jazz Pharmaceuticals, an Ireland-based company famous for its ‘Ziihera’ (zanidatamab), which is a prescription-based medicine have been serving a total of 75 countries with i...

Arrowhead put the weight on Tirzepatide to help the obese population
Date 09 January 2026

Arrowhead put the weight on Tirzepatide to help the obese population

Announcement Arrowhead is headed to double the Tirzepatide’s weightloss in the combinational study. After proving its excellence in therapies to cure the diseases causing genes, the company has...

TYBR Health's new gel formulation to heal post-surgical wounds
Date 08 January 2026

TYBR Health's new gel formulation to heal post-surgical wounds

Announcement TYBR Health is a known Houston-related regenerative medicine and medical technology company popular for its establishment in biomaterials therapies to refine post-operative recovery. The...

GenEditBio's Application went on another desk for the TGFBI Corneal Dystrophy
Date 08 January 2026

GenEditBio's Application went on another desk for the TGFBI Corneal Dystrophy

Announcement GenEditBio stepped into the biotech competition in 2021 with one goal and mission in mind to serve vivo genome-editing therapeutic solutions. The company now excitedly declared that its ...

BioAtla and GATC initiate SPV transaction to bolster the ongoing study
Date 06 January 2026

BioAtla and GATC initiate SPV transaction to bolster the ongoing study

Announcement BioAtla, Inc., a leading clinical-level biotechnology company focusing on the establishment of Conditionally Active Biologic (CAB) antibody therapeutics for solid tumor treatment, has jo...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.